CLOUDR GROUP LIMITED Financials ClouDr Group Limited
Equities
9955
KYG2216H1011
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.34 HKD | +0.91% |
|
-2.33% | -51.09% |
| 04-15 | ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services | MT |
| 03-22 | ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5% | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 6,958 | 3,655 | 1,798 | - | - |
| Enterprise Value (EV) 1 | 6,728 | 3,655 | 1,445 | 1,693 | 2,982 |
| P/E ratio | -2.11 x | -10.4 x | -15.7 x | 45.4 x | 28.9 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 2.33 x | 0.99 x | 0.38 x | 0.31 x | 0.27 x |
| EV / Revenue | 2.25 x | 0.99 x | 0.3 x | 0.29 x | 0.44 x |
| EV / EBITDA | -13.7 x | -15.3 x | 24.9 x | 7.34 x | 7.26 x |
| EV / FCF | -8,307,146 x | - | - | - | - |
| FCF Yield | -0% | - | - | - | - |
| Price to Book | 3.76 x | - | 1.14 x | 1.03 x | 0.75 x |
| Nbr of stocks (in thousands) | 587,038 | 587,038 | 587,038 | - | - |
| Reference price 2 | 11.85 | 6.226 | 3.063 | 3.063 | 3.063 |
| Announcement Date | 23-03-22 | 24-03-21 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,988 | 3,691 | 4,762 | 5,849 | 6,755 |
| EBITDA 1 | - | -489.5 | -239.4 | 57.93 | 230.6 | 410.5 |
| EBIT 1 | - | -591.6 | -314.2 | -26.11 | 136.5 | 252.3 |
| Operating Margin | - | -19.8% | -8.51% | -0.55% | 2.33% | 3.74% |
| Earnings before Tax (EBT) 1 | - | - | - | -173 | -121 | - |
| Net income 1 | -4,139 | -1,689 | -323.1 | -77.16 | 71.08 | - |
| Net margin | - | -56.52% | -8.75% | -1.62% | 1.22% | - |
| EPS 2 | -42.88 | -5.620 | -0.6000 | -0.1951 | 0.0675 | 0.1061 |
| Free Cash Flow | - | -809.9 | - | - | - | - |
| FCF margin | - | -27.1% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 22-06-23 | 23-03-22 | 24-03-21 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 1,185 |
| Net Cash position 1 | - | 230 | - | 353 | 105 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | 2.885 x |
| Free Cash Flow | - | -810 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | 5.77% | 14.1% | 14.9% |
| ROA (Net income/ Total Assets) | - | -12.5% | - | -0.05% | 3.52% | - |
| Assets 1 | - | 13,557 | - | 152,793 | 2,018 | - |
| Book Value Per Share 2 | - | 3.150 | - | 2.690 | 2.980 | 4.080 |
| Cash Flow per Share 2 | - | - | - | -0.0200 | 0.1700 | 0.7800 |
| Capex 1 | - | 167 | - | 153 | 169 | 309 |
| Capex / Sales | - | 5.6% | - | 3.21% | 2.89% | 4.57% |
| Announcement Date | 22-06-23 | 23-03-22 | 24-03-21 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.063
CNY
Average target price
6.328
CNY
Spread / Average Target
+106.61%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -51.09% | 249M | |
| -4.72% | 182B | |
| +3.96% | 114B | |
| -2.93% | 68.38B | |
| +6.30% | 52.46B | |
| +8.02% | 44.25B | |
| +7.52% | 43.55B | |
| +26.18% | 32.69B | |
| +17.85% | 26.73B | |
| +0.57% | 25.79B |
- Stock Market
- Equities
- 9955 Stock
- Financials ClouDr Group Limited
